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There is a marked racial disparity in the treat-
ment of patients with coronary artery and cere-
brovascular occlusive diseases. African Americans are
significantly less likely than whites to undergo car-
diac catheterization, coronary angioplasty, and coro-
nary artery bypass grafting.1-6 Similarly, African
Americans are significantly less likely to undergo cere-
bral arteriography and carotid endarterectomy.7-10
However, the impact of race on the treatment of
patients with peripheral artery occlusive disease
(PAOD) remains less clear. Study results from both
Maryland11 and Massachusetts12 have reported that
African Americans are more likely than whites to
undergo surgical bypass grafting for PAOD,
although the opposite results were reported from
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Purpose: The purpose of this study was to determine the impact of race on the treatment
of peripheral artery occlusive disease (PAOD) and to examine the role of access to care
and disease distribution on the observed racial disparity.
Methods: The study was performed as a retrospective analysis of hospital discharge
abstracts from 1992 to 1995 in 202 non-federal, acute-care hospitals in the state of
Florida. The subjects were patients older than 44 years of age who underwent major
lower extremity amputation or revascularization (bypass grafting or angioplasty) for
PAOD. The main outcome measures were incidence of intervention, incidence per demo-
graphic group, multivariate predictors of amputation versus revascularization, multi-
variate predictors of amputation versus revascularization among those patients with
access to sophisticated care (hospital with arteriographic capabilities), and multivariate
predictors of surgical bypass graft type (aortoiliac vs infrainguinal).
Results: A total of 51,819 procedures (9.1 per 10,000 population) were performed for
PAOD during the study period and included 15,579 major lower extremity amputations
(30.1%) and 36,240 revascularizations (69.9%). Although the incidence of a procedure
for PAOD was comparable between African Americans and whites (9.0 vs 9.6 per
10,000 demographic group), the incidence of amputation (5.0 vs 2.5 per 10,000 demo-
graphic group) was higher and the incidence of revascularization (4.0 vs 7.1 per 10,000
demographic group) was lower among African Americans. Furthermore, multivariate
analysis results showed that African Americans (odds ratio, 3.79; 95% confidence inter-
val [CI], 3.34 to 4.30) were significantly more likely than whites to undergo amputa-
tion as opposed to revascularization. The secondary multivariate analyses results revealed
that African Americans (odds ratio, 2.29; 95% CI, 1.58 to 3.33) were more likely to
undergo amputation among those patients (n = 9193) who underwent arteriography
during the procedural admission and to undergo infrainguinal bypass grafting (odds
ratio, 2.00; 95% CI, 1.48 to 2.71) among those patients (n = 27,796) who underwent
surgical bypass grafting.
Conclusion: There is a marked racial disparity in the treatment of patients with PAOD
that may be caused in part by differences in the severity of disease or disease distribu-
tion. (J Vasc Surg 1999;30:417-26.)
417
From the Departments of Surgery (Drs Huber, Ozaki, Flynn, and
Seeger) and Health Policy and Epidemiology (Drs Wheeler and
Cuddeback, Mr Wang, and Mr Dame), University of Florida
College of Medicine; Duke University School of Medicine (Dr
Wheeler); the Department of Health Policy (Dr Cuddeback
and Mr Dame), Shands Health Care; and the Department of
Surgery (Drs Ozaki and Flynn), Gainesville Veterans
Administration Medical Center.
Presented at the Twenty-third Annual Meeting of The Southern
Association for Vascular Surgery, Naples, Fla, Jan 27–30, 1999.
Reprint requests: Dr Thomas S. Huber, Section of Vascular
Surgery, Department of Surgery, PO Box 100286, University
of Florida College of Medicine, Gainesville, FL 32610-0286.
Copyright © 1999 by the Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/6/99682
the national Medicare database.13 In addition, study
results from both state11,14 and national databases13
have reported that African Americans are more like-
ly to undergo amputation as treatment for PAOD.
There are several possible explanations for these
observed racial disparities in the treatment of
patients with PAOD, including differential access to
care, variations in disease distribution, delay in pre-
sentation, distrust in the medical system, and racial
bias among health care providers. Notably, Sidaway
et al15 graded 135 infrageniculate arteriograms and
reported that African Americans had more severe
disease per arterial segment. This study was designed
to determine the impact of race on the treatment of
patients with PAOD and to examine the potential
role of access to care and disease distribution on the
observed racial disparity with the state of Florida
hospital discharge database.
PATIENTS AND METHODS
Data were obtained from the Florida Agency for
Health Care Administration (AHCA) database for
patients who underwent either major lower extremity
amputation or lower extremity revascularization dur-
ing the calendar years 1992 through 1995.10 The
AHCA database contains an abstract record for each
inpatient hospitalization in the 202 non-federal, gen-
eral, acute-care hospitals throughout the state. These
records contain up to 10 diagnosis and 10 procedure
codes from the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM),16
along with the Diagnosis Related Group (Federal
Health Care Financing Administration), insurance sta-
tus, and patient demographics (age, race, gender, and
zip code).
A dataset of all the hospitalizations in which
patients underwent treatment for PAOD during the
study period was constructed. Major lower extremity
amputations were identified with the following ICD-
9-CM procedure codes: 84.13, disarticulation of
ankle; 84.14, amputation of ankle through malleoli
of tibia and fibula; 84.15, other amputation below
knee; 84.16, disarticulation of knee; and 84.17,
amputation above knee.13 Digital, ray, and forefoot
amputations were considered minor and were not
included in the analyses. Similarly, hip disarticulations
were excluded from the analysis because the proce-
dures are rarely performed for complications of
PAOD. Lower extremity arterial revascularizations
were identified with the procedure code 39.59 (other
repair of vessel including arterioplasty) for percuta-
neous transluminal angioplasty and the procedure
codes 39.25 (aorto-iliac-femoral bypass grafting) and
39.29 (other peripheral vascular bypass grafting) for
surgical bypass grafting.11,13 A hierarchy of the pro-
cedures was constructed to avoid duplicate analysis of
the hospitalizations during which patients underwent
more than one procedure, and the hospitalization
was analyzed with the highest procedure in the hier-
archy.13 The hierarchy was constructed in ascending
order from percutaneous transluminal angioplasty,
aortoiliac-femoral bypass grafting, peripheral artery
bypass grafting, below-knee amputation (84.13 to
84.15), to above-knee amputation (84.16 to 84.17).
Patients younger than 45 years of age were excluded
from the dataset because of the relative infrequency
of interventions for PAOD in this subset of patients.
The dataset was further refined in an attempt to iden-
tify hospitalizations during which patients underwent
major lower extremity amputation or revasculariza-
tion for complications of PAOD.11,13 The ICD-9-
CM diagnostic codes were reviewed, and the analysis
was restricted to those patients with primary or sec-
ondary diagnostic codes that were likely related to
PAOD. These codes included the following: 40.0,
gas gangrene; 250, diabetes mellitus; 440, athero-
sclerosis; 443, other peripheral vascular disease; 444,
arterial embolism and thrombosis; 447.1, stricture of
artery; 447.8, unspecified disorders of arteries and
arterioles; 681.1, cellulitis and abscess of toe; 682.6,
cellulitis and abscess leg, except foot; 682.7, cellulitis
and abscess foot, except toes; 707, chronic ulcer of
skin; 730.0X, acute osteomyelitis (.06, lower leg; .07,
ankle and foot; .09, unspecified); 730.1X, chronic
osteomyelitis (.06, lower leg; .07, ankle and foot;
.09, unspecified); 730.2X, osteomyelitis unspecified
(.06, lower leg; .07, ankle and foot; .09, unspecified);
785.4, gangrene; 996.1, mechanical complication of
vascular device; 996.62, inflammation and infection,
vascular device; 996.74, other complication, vascular
device; 996.79, other complication, prosthetic
device; and 997.2, peripheral vascular complication.
The diagnostic code for peripheral artery aneurysms
(442.3) was not included among those codes used to
identify patients with PAOD.
The dataset of all patients older than 44 years of
age who underwent intervention for the complica-
tions of PAOD was further analyzed with patient
demographics (gender, age, and race). The patient
demographics in the AHCA database were obtained
with self report or with observation at the time of
hospital admission and were complete in all the
abstracts. Patient race was classified in the AHCA
database as black, white, or other, with black
Hispanic and white Hispanic groups classified as
black and white, respectively. The total number of
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procedures and the number of major lower extrem-
ity amputations and revascularizations were
expressed as a rate per 10,000 state population and
per 10,000 demographic group. The estimated state
population, including the breakdown by demo-
graphic group, was obtained from the Bureau of
Economic and Business Research at the University
of Florida and was based on the United States
Census data.10
The dataset of all patients older than 44 years
who underwent intervention for the complications
of PAOD was further analyzed to look at the pre-
dictors of major lower extremity amputation versus
revascularization with a multivariate logistic model
comprised of both single and interaction variables.
The single variables included age group, gender,
race, insurance status, comorbidities, hospital vol-
ume, and diagnostic codes related to PAOD. The
patients were classified as indigent if their principal
payor code in the AHCA database was Medicaid,
Medicaid HMO, self pay/underinsured (less than
30% estimated insurance), or charity. The patient
comorbidities were identified with the ICD-9-CM
diagnositic codes for hypertension (401), diabetes
mellitus (250), coronary artery disease (414, 414.0,
414.8, 414.9), renal failure (584, 585, 586), and
congestive heart failure (428.0). The hospitals were
classified as either high volume or low volume on
the basis of the total number of surgical bypass graft-
ing procedures performed for PAOD. The institu-
tions were ranked in descending order by the vol-
ume of surgical bypass grafting procedures, and the
high-volume hospitals were arbitrarily defined as
those that accounted for two thirds of the total
number of procedures. The relevant diagnostic
codes were condensed from the previous extensive
list and included gangrene (40.0, 785.4), arterial
embolism and thrombosis (444), cellulitis and
abscess (681.1, 682.6, 682.7), chronic ulcer of skin
(707.0, 707.1, 707.8, 707.9), and osteomyelitis
(730.06, 730.07, 730.09, 730.16, 730.17, 730.19,
730.26, 730.27, 730.29). The interaction variables
included race/diabetes, race/hospital volume, and
race/indigent status. The interaction variables were
included in the model to determine whether a vari-
able had a different effect on the treatment choice
depending on the value of other variables in the
model.13 In the presence of interactions, the main
effect may not be interpreted separately. Secondary
multivariate analyses were performed in the subset of
patients (n = 9193) who underwent arteriography
during the procedural admission in an attempt to
investigate the potential significance of access to
sophisticated health care. This was on the basis of
the assumption that if a patient underwent arteriog-
raphy then the patient had access to a health care
system that was sufficiently sophisticated to perform
arterial revascularization. The patients who under-
went arteriography were identified with the proce-
dural code 88.47 (arteriography of femoral and
other lower extremity). Secondary analyses were also
performed among those patients (n = 27,796) who
underwent surgical bypass grafting (vs endovascular
revascularization; ie, angioplasty) to look at the pre-
dictors of aortoiliac-femoral bypass grafting versus
infrainguinal bypass grafting. This analysis was per-
formed in an attempt to look at the distribution of
disease (aortoiliac vs infrainguinal) among the
patient groups.
The incidence of an intervention for PAOD and
the breakdown by amputation and revascularization
were compared among gender, race, and age groups
with c 2 test. The multivariate odds ratios of the var-
ious treatment options are reported with 95% confi-
dence interval (CI). A P value of less than .05 was
accepted as significant. All the data analyses were
performed with SAS version 6.11 (SAS Institute Inc,
Cary, NC) running under AIX version 4.2 on an
IBM RS/6000-59H computer (International
Business Machines Co, Armonk, NY).
RESULTS
A total of 51,819 procedures were performed for
the complications of PAOD among patients older
than 44 years of age in the state of Florida during
the calendar years 1992 to 1995. Major lower
extremity amputation was performed in 15,579
cases (30.1%), and lower extremity revascularization
was performed in 36,240 cases (69.9%). This corre-
sponded to an annual rate of 9.4 procedures per
10,000 state residents, with a breakdown of 2.8
amputations and 6.6 revascularizations.
The incidences of procedures performed for the
complications of PAOD and the breakdown of the
procedure type (amputation vs revascularization)
were both found to vary significantly with gender,
race, and age (Table I). Male patients were more
likely to undergo a procedure for PAOD (annual
incidence per 10,000 demographic group, 11.2 vs
7.8), and both the incidences of amputation (3.1 vs
2.6) and revascularization (8.0 vs 5.3) were higher
in male patients. Furthermore, the likelihood of a
procedure for PAOD was comparable between
whites and African Americans (9.6 vs 9.0), but the
type of treatment varied dramatically. African
Americans were more likely than whites to undergo
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amputation (5.0 vs 2.5) and less likely to undergo
revascularization (4.0 vs 7.1). Notably, African
Americans were more likely to undergo amputation
than revascularization for treatment of PAOD.
Specifically, African Americans underwent amputa-
tion 56% of the time in contrast to whites who
underwent amputation only 26% of the time.
Finally, the incidence of an intervention for the com-
plications of PAOD increased with age and the inci-
dence among patients older than 84 years of age was
46.7 procedures per 10,000 demographic group.
The breakdown of procedure type was comparable
among the four youngest age classifications (45 to
54 years through 75 to 84 years) despite the pro-
gressive increased incidence of interventions with
age: amputation was performed 30% of the time. In
contrast, patients older than 84 years of age were
more likely to undergo amputation than revascular-
ization (59.4% vs 40.6%).
Multivariate analysis results of the overall dataset
(n = 51,819) showed that several variables had a sig-
nificant impact on the treatment option (Table II).
Patients in the 45-year-old to 54-year-old age group
and those older than 74 years were more likely than
the reference group (65 to 74 years) to undergo
amputation, and the odds ratio for those patients
older than 84 years was 4.05 (95% CI, 3.73 to 4.40).
Female patients were also significantly more likely to
undergo amputation (odds ratio, 1.07; 95% CI, 1.02
to 1.12), although the magnitude of the difference
was small. Race again had a dramatic impact on the
treatment of PAOD: African Americans were far
more likely than whites to undergo amputation than
revascularization, with an odds ratio of 3.79 (95%
CI, 3.34 to 4.30). Not surprisingly, the presence of
diabetes mellitus (odds ratio, 1.60; 95% CI, 1.52 to
1.69), congestive heart failure (odds ratio, 1.63;
95% CI, 1.54 to 1.74), renal failure (odds ratio,
1.22; 95% CI, 1.12 to 1.34), gangrene (odds ratio,
7.59; 95% CI, 7.20 to 8.01), cellulitis (odds ratio,
1.27; 95% CI, 1.17 to 1.37), ulceration (odds ratio,
1.32; 95% CI, 1.24 to 1.41), and osteomyelitis
(odds ratio, 2.87; 95% CI, 2.57 to 3.21) all
increased the likelihood of amputation. Further-
more, the likelihood of amputation for the treat-
ment of PAOD was greater among indigent patients
(odds ratio, 1.61; 95% CI, 1.43 to 1.82) and the
likelihood was less among those patients who under-
went treatment at high-volume institutions (odds
ratio, 0.72; 95% CI, 0.68 to 0.76). The presence of
diabetes mellitus and indigent status also were found
to interact with race in the multivariate model and
thereby affected the odds ratios of the underlying
treatment options. However, the odds ratios for
amputation among patients with diabetes and those
patients classified as indigent were still dramatically
greater for African Americans as compared with
whites (diabetic/African American: odds ratio, 2.55;
95% CI, 25 to 2.88; indigent/African American:
odds ratio, 2.40; 95% CI, 1.91 to 3.02).
Multivariate analysis results of the subset of
patients who underwent arteriography during the
procedural admission (n = 9193) also identified sev-
eral variables that impacted the treatment option for
patients with PAOD (Table II). Patients older than
84 years of age were still more likely to undergo
amputation than revascularization (odds ratio, 1.82;
95% CI, 1.46 to 2.28) relative to the reference
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Table I. Breakdown of procedures by demographic group
No. of No. of No. of 
Parameter procedures Incidence* amputations (%) Incidence* revascularizations (%) Incidence*
Gender†‡
Male 29,572 11.2 8281 (28.0) 3.1 21,291 (72.0) 8
Female 22,247 7.8 7298 (32.8) 2.6 14,949 (67.2) 5.3
Race†‡
White 44,266 9.6 11,473 (25.9) 2.5 32,793 (74.1) 7.1
African American 7071 9 3956 (55.9) 5 3115 (44.1) 4
Other 482 5.4 150 (31.1) 1.7 332 (68.9) 3.7
Age (years)†‡
45 to 54 4090 6.6 1101 (26.9) 1.8 2989 (73.1) 4.9
55 to 64 9259 18.1 2376 (25.7) 4.6 6883 (74.3) 13.5
65 to 74 18,821 33.1 4456 (23.7) 7.8 14,365 (76.3) 25.3
75 to 84 14,950 40 4854 (32.3) 13 10,096 (67.7) 27.1
>84 4702 46.7 2792 (59.4) 27.8 1907 (40.6) 18.9
*Incidence per 10,000 demographic group.
†Significant difference in incidence of procedure by demographic group with c 2 test, P < .05.
‡Significant difference in treatment breakdown (amputation vs revascularization) by demographic group with c 2 test, P < .05.
group, but there were no significant differences for
the other age classifications. African Americans were
still far more likely than whites to undergo amputa-
tion than revascularization, with an odds ratio of
2.29 (95% CI, 1.58 to 3.33), but there was no dif-
ference by gender. The presence of congestive heart
failure (odds ratio, 1.61; 95% CI, 1.36 to 1.92),
renal failure (odds ratio, 1.47; 95% CI, 1.13 to
1.90), and gangrene (odds ratio, 5.68; 95% CI, 4.93
to 6.54) all were associated with an increased likeli-
hood of amputation, and the presence of diabetes
had no effect. Indigent patients were again more
likely to undergo amputation (odds ratio, 1.44; 95%
CI, 1.03 to 2.22), and those patients who under-
went treatment at a high-volume hospital (odds
ratio, 0.75; 95% CI, 0.64 to 0.87) were still more
likely to undergo revascularization.
Multivariate analysis results of the subset of
patients who underwent surgical bypass grafting (n
= 27,796) identified several variables that were asso-
ciated with an increased likelihood of infrainguinal
(vs aortoiliac) bypass grafting. Patients in the two
youngest age groups (45 to 54 years, 55 to 64 years)
were significantly more likely than the reference
JOURNAL OF VASCULAR SURGERY
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Table II. Multivariate analysis of the predictors of amputation versus revascularization
All amputations and Arteriography during
revascularizations (n = 51,819) admission (n = 9193)
Variable Odds ratio Confidence interval Odds ratio Confidence interval
Age (years)
45 to 54* 1.11† 1.01 to 1.23 1.18 0.90 to 1.54
55 to 64 0.97 0.90 to 1.05 0.97 0.78 to 1.19
65 to 74 — — — —
75 to 84 1.55† 1.46 to 1.64 1.12 0.95 to 1.32
>84 4.05† 3.73 to 4.40 1.82† 1.46 to 2.28
Gender 
Male* — — — —
Female 1.07† 1.02 to 1.12 0.98 0.87 to 1.14
Race
White* — — — —
African American 3.79† 3.34 to 4.30 2.29† 1.58 to 3.33
Other 0.98 0.60 to 1.61 1.4 0.33 to 6.06
Insurance status
Insured — — — —
Indigent 1.61† 1.43 to 1.82 1.44† 1.03 to 2.00
Comorbidities
No condition* — — — —
Diabetes mellitus 1.60† 1.52 to 1.69 1.13 0.97 to 1.32
Hypertension 0.71† 0.67 to 0.74 0.70† 0.60 to 0.81
Coronary artery disease 0.77† 0.73 to 0.81 0.79† 0.67 to 0.93
Congestive heart failure 1.63† 1.54 to 1.74 1.61† 1.36 to 1.92
Renal failure 1.22† 1.12 to 1.34 1.47† 1.13 to 1.90
Diagnostic code
No condition* — — — —
Gangrene 7.59† 7.20 to 8.01 5.68† 4.93 to 6.54
Embolism/thrombosis 0.27† 0.26 to 0.29 0.76† 0.66 to 0.87
Cellulitis/abscess 1.27† 1.17 to 1.37 1.09 0.89 to 1.33
Chronic ulcer 1.32† 1.24 to 1.41 0.78† 0.65 to 0.93
Osteomyelitis 2.87† 2.57 to 3.21 0.58† 0.40 to 0.84
Hospital characteristics
Low hospital volume* — — — —
High hospital volume 0.72† 0.68 to 0.76 0.75† 0.64 to 0.87
Interaction parameters
Diabetes/African American vs white 2.55‡ 2.25 to 2.88 2.48 1.72 to 3.57
Diabetes/others vs white 1.22 0.75 to 1.97 1.25 0.33 to 4.72
High-volume hospital/African American vs white 3.45 3.10 to 3.83 2.3 1.74 to 3.05
High-volume hospital/others vs white 1.08 0.70 to 1.67 0.99 0.28 to 3.45
Indigent/African American vs white 2.40‡ 1.91 to 3.02 1.85 1.03 to 3.32
Indigent/others vs white 0.69 0.30 to 1.55 § §
*Baseline group for comparisons.
†Significant at P < .05.
‡Significant interaction between race and diabetes or indigent status at P < .05.
§Insufficient number of observations for analysis.
group (65 to 74 years) to undergo aortoiliac bypass
grafting, and those in the two oldest age groups (75
to 84 years, >84 years) were more likely to undergo
infrainguinal bypass grafting. Notably, the odds ratio
for patients older than 84 years of age was 5.15 (95%
CI, 4.04 to 6.57). Interestingly, female patients were
significantly more likely to undergo aortoiliac bypass
grafting (odds ratio, 0.84; 95% CI, 0.78 to 0.89),
although the difference was small. African
Americans who underwent bypass grafting for the
complications of PAOD were twice as likely (odds
ratio, 2.00; 95% CI, 1.48 to 2.71) to undergo
infrainguinal bypass grafting than were whites.
Predictably, the presence of diabetes (odds ratio,
2.26; 95% CI, 2.08 to 2.45), gangrene (odds ratio,
2.31; 95% CI, 1.97 to 2.70), cellulitis/abscess (odds
ratio, 2.85; 95% CI, 2.24 to 3.63), chronic ulcer
(odds ratio, 2.10; 95% CI, 1.81 to 2.44), and
osteomyelitis (odds ratio, 2.52; 95% CI, 1.59 to
3.99) all were associated with a marked increased
likelihood of infrainguinal bypass grafting.
Surprisingly, the insurance status of the patient did
not affect the odds ratio of the type of bypass graft-
ing. Patients who underwent treatment at a high-
volume hospital were more likely to undergo aor-
toiliac bypass grafting (odds ratio, 0.85; 95% CI,
0.81 to 0.93).
DISCUSSION
This study shows that the incidence of treatment
for the complications of PAOD in the state of
Florida was comparable between whites and African
Americans, although the type of treatment was
markedly different. African Americans were more
likely to undergo amputation than revascularization
for treatment of PAOD, and the odds ratio (ampu-
tations vs revascularization) was four-fold greater
when compared with whites. African Americans who
underwent arteriography during the procedural
admission, the marker for sophisticated health care,
were twice as likely to undergo amputation than
revascularization when compared with whites.
Lastly, African Americans were twice as likely to
undergo infrainguinal rather than aortoiliac bypass
grafting when compared with whites.
The observed racial disparity in the treatment of
patients with PAOD is supported by similar studies
from both state11,12,14 and national databases.13
Notably, Tunis et al11 reported that African
Americans in Maryland (n = 7080; 1988 to 1989)
were significantly more likely than whites to under-
go a procedure (amputation, surgical bypass graft-
ing, angioplasty) for PAOD and that they were sig-
nificantly more likely to undergo lower extremity
amputation and surgical bypass grafting but less like-
ly to undergo angioplasty. The multivariate analysis
results in their study yielded remarkably similar find-
ings to our study in that African American race, dia-
betes, and indigent status all increased the likelihood
of amputation (vs revascularization), although the
odds ratio for African Americans was only 2.54.
Brothers et al14 reported that African Americans in
South Carolina (n = 1077; October 1992 to
September 1993) were more likely than whites to
undergo amputation and infrainguinal revasculariza-
tion but less likely to undergo aortoiliac revascular-
ization by means of univariate analysis. Guadagnoli
et al13 reported from a 20% sample (n = 19,236;
1989 to 1990) of Medicare beneficiaries (>64 years)
that African Americans were more likely to undergo
all types of lower extremity amputation but less like-
ly to undergo angioplasty or surgical revasculariza-
tion by means of both univariate and multivariate
analysis. Our study corroborates these findings and
significantly strengthens the overall observations by
virtue of the magnitude of our sample size (n =
51,819), the broad age range of patients analyzed
(>44 years), the all-encompassing inclusion criteria
(ie, no restriction by payor), and the rigorousness of
the multivariate model.
Our data suggest that part of the observed racial
disparity for the treatment of PAOD was caused by
the severity of disease or the disease distribution at
the time of presentation. The observation that
African Americans were more likely to undergo
amputation despite arteriography during procedural
admission suggests that a higher percentage of
African Americans had conditions that were not
reconstructable or were not bypass graft candidates.
This reasoning is contingent on the assumption that
patients who underwent arteriography had gained
access to a health care system sufficiently sophisticat-
ed to perform arterial bypass grafting surgery and
that arteriography was obtained as a preoprocedural
test to plan the intervention. Indeed, this is the role
of arteriography for patients with PAOD in our own
practice. Patients who are not deemed candidates for
revascularization (ie, no conduit, unsalvageable foot,
nonambulatory, prohibitive operative risk) would
not be subjected to arteriography and the inherent
cost/risk. The observation that African Americans
were more likely to undergo infrainguinal bypass
grafting procedures than were whites suggests a
higher prevalence of disease in the corresponding
anatomic distribution. This reasoning is confounded
by the fact that the operative indications were not
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available in the database, and therefore it is not clear
whether the various bypass grafting procedures (aor-
toiliac vs infrainguinal) were performed for claudica-
tion, rest pain, or tissue loss. It is conceivable,
although not likely, that the racial breakdown of
procedures was skewed by the fact that whites
underwent a greater number of aortoiliac bypass
grafting procedures for claudication. As noted previ-
ously, Sidaway et al15 reported that African
Americans had more severe infrageniculate disease in
a small, retrospective analysis of arteriograms.
Further indirect evidence for a differences in disease
distribution or severity of disease by race is provided
by the observation of Tunis et al11 that African
Americans were less likely to undergo angioplasty.
Angioplasty has been proven to be most beneficial
for short segment stenoses in the common iliac
arteries,17 and therefore the lower usage rate among
African Americans may be caused by a lower inci-
dence of occlusive disease amenable to angioplasty as
a result of a difference in either disease distribution
or extent.
The explanations for the differences in distribu-
tion or severity of the PAOD among African
Americans are speculative and cannot be determined
from our data analyses. It is conceivable that African
Americans are genetically predisposed to have ather-
osclerosis develop in the infrainguinal distribution.
Notably, the incidence of both extracranial carotid18-
20 and coronary artery occlusive disease21,22 is lower
among African Americans and likely explains part of
the observed racial disparity for the treatment of
these problems. The increased severity of PAOD may
be the result of a higher prevalence of the cardiovas-
cular risk factors among African Americans. Indeed,
serum nicotine metabolites23 and the incidences of
diabetes,24,25 hypertension,26-29 and obesity28 are
higher among African Americans. Furthermore, the
incidence of comorbidities,30 including cardiac
comorbidities,31 are increased among African
Americans. The increased severity of occlusive disease
among African Americans may also be the result of
socioeconomic differences that contribute to delays
in presentation, poor access to care, poor access to
quality care, and poor compliance. Indigent status
was associated with an increased incidence of ampu-
tation in the multivariate model and was found to
interact with race. The impact of socioeconomic sta-
tus on health care is emphasized by a study from
Gittelsohn et al32 that analyzed the medical and sur-
gical admission in the state of Maryland. They
reported that African Americans and the poor have a
higher illness burden that necessitates hospitalization
and that discretionary surgical procedures have a
white predominance and increase with income.
Interestingly, Kaufman et al33 analyzed the impact of
race and socioeconomic status in several large epi-
demiologic studies and concluded that the observed
racial/ethnic differences were more likely caused by
socioeconomic factors that were not appropriately
accounted for in the methodologies than by a true
racial difference.
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Table III. Multivariate analysis of the predictors of
infrainguinal versus aortoiliac surgical revascularization
Surgical revascularization
(n = 27,796)
Variable Odds ratio Confidence interval
Age (years)
45 to 54* 0.52† 0.47 to 0.58
55 to 64 0.71† 0.65 to 0.77
65 to 74 — —
75 to 84 1.93† 1.77 to 2.09
>84 5.15† 4.04 to 6.57
Gender 
Male* — —
Female 0.84† 0.78 to 0.89
Race
White* — —
African American 2.00† 1.48 to 2.71
Other 1.03 0.52 to 2.02
Insurance status
Insured — —
Indigent 0.99 0.86 to 1.15
Comorbidities
No condition* — —
Diabetes mellitus 2.26† 2.08 to 2.45
Hypertension 1.13† 1.05 to 1.20
Coronary artery disease 0.99 0.92 to 1.06
Congestive heart failure 0.77† 0.70 to 0.85
Renal failure 0.65† 0.56 to 0.75
Diagnostic code
No condition* — —
Gangrene 2.31† 1.97 to 2.70
Embolism/thrombosis 0.68† 0.63 to 0.72
Cellulitis/abscess 2.85† 2.24 to 3.63
Chronic ulcer 2.10† 1.81 to 2.44
Osteomyelitis 2.52† 1.59 to 3.99
Hospital characteristics
Low hospital volume* — —
High hospital volume 0.85† 0.81 to 0.93
Interaction parameters*
Diabetes/African- 2.59 1.80 to 3.73
American vs white
Diabetes/others vs white 1.07 0.44 to 2.59
High-volume hospital/ 1.84 1.51 to 2.24
African American vs white
High-volume hospital/ 1.19 0.71 to 1.99
others vs white
Indigent/African American 1.39 0.91 to 2.13
vs white
Indigent/others vs white 2.02 0.57 to 7.16
*Baseline group for comparisons.
†Significant at P < .05.
Several additional features of the database and
the analyses merit further comment. The AHCA
database is an administrative one that was adapted to
ask specific clinical questions. The abstracts in the
database are generated retrospectively by trained
medical coders, and therefore, there is likely some
error in the accuracy and completeness of the diag-
nostic and procedural codes. However, it is unlikely
that there was a difference in the reliability of the
coding by patient race. The abstracts contain a finite
quantity of information that does not include the
indication for the operative procedure. It is conceiv-
able that the analysis of the patients who underwent
intervention for claudication or limb-threatening
ischemia (rest pain or tissue loss) would have yield-
ed different results. In addition, the abstracts in the
database reflect discrete hospitalizations rather than
specific patients because no specific patient identi-
fiers were used in the analyses. A subset of patients
likely required more than one hospitalization with
intervention for PAOD. Indeed, Guadagnoli et al13
reported that 13% of the patients in their analysis of
Medicare beneficiaries required repeated hospitaliza-
tions. The procedural code that we used to identify
patients who underwent infrainguinal bypass graft-
ing (39.29, other vascular shunt or bypass graft)
included several additional procedures (axillary-
brachial, axillary-femoral, brachial, etc). Therefore,
our results should be interpreted with some caution.
However, the overall number of these additional
types of procedure is likely small in terms of both
absolute numbers and relative to the number of
infrainguinal bypass grafting procedures. In addi-
tion, only the patients with primary and secondary
diagnostic codes for PAOD were included in the
analysis. Notably, Brothers et al14 reported similar
findings (African Americans were more likely to
undergo infrainguinal bypass grafting than were
whites) with more specific procedure codes.
Similarly, the angioplasty code (39.59, other repair
of vessels, including angioplasty) was fairly nonspe-
cific and potentially included procedures in addition
to peripheral angioplasty. The requirements of a
diagnostic code related to PAOD and the hierarchy
of procedures used likely minimized the influence of
these additional procedures. Tunis et al34 reported
that this approach underestimated the number of
angioplasties by approximately 15%. Lastly, the mag-
nitude of the sample size (n = 51,819) was both an
advantage and a disadvantage. It allowed us to con-
struct a complex logistic model to interrogate mul-
tiple variables. However, statistical significance was
achieved despite what would be considered a fairly
insignificant clinical difference (ie, female patients
were more likely to undergo amputation as opposed
to revascularization, with an odds ratio of 1.07; 95%
CI, 1.02 to 1.12).
There is a marked racial disparity in the treatment
of PAOD in the state of Florida. The observed dis-
parity may be partly explained by a difference in the
severity of disease or distribution. This racial disparity
mandates further investigation to elucidate the
responsible mechanisms so that health care policy may
be redirected. Regardless of the underlying mecha-
nisms, disproportionate numbers of African
Americans are undergoing amputation for treatment
of PAOD. This has a profound socioeconomic impact
in light of the limited ambulation, long-term costs,
and limited life expectancy among these patients.
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DISCUSSION
Dr Kimberley J. Hansen (Gainesville, Fla).
The information presented is an important contribu-
tion to the increasing evidence that blacks in our country
receive different intervention for peripheral vascular dis-
ease than do whites.
In a retrospective review of more than 50,000 hospi-
talizations meeting the authors’ procedure and diagnostic
coding criteria for major lower extremity amputation or
revascularization, the incidence of intervention was simi-
lar, but the type of intervention differed for blacks and
whites in the state of Florida. Blacks demonstrated a
greater proportion of amputations, which was statistically
significant and independent as compared with whites, a
difference that persisted when racial interactions between
diabetes and indigent status were considered.
Bearing in mind the enormous statistical power pro-
vided with more than 50,000 subjects, it is important to
note that this difference was also clinically significant: 60%
of blacks underwent amputations as compared with 25%
of whites.
Given the consequences of amputation on both the
quality and quantity of life, these differences are sobering,
but they remain largely unexplained. This is not to fault
the authors’ rigorous statistical analysis but reflects the
limitations of the dataset. The Florida Agency for Health
Care Administration Database and other state databases
like it were not constructed to answer the key clinical
question: what accounts for these racial differences?
Given the causes for this racial disparity and given the
reason that these causes can only be inferred from these
aggregate data, which were intended really to address hos-
pital billing issues, I have the following questions.
In selecting the dataset, how many patients with pro-
cedural codes chosen for amputation or revascularization
were rejected on the basis of diagnostic codes considered
inconsistent with peripheral vascular disease? Was an analy-
sis performed or could an analysis be performed to exam-
ine whether the assumptions made with these diagnostic
codes achieved the desired case selection?
Hispanic patients were considered as either African
American or white. Assuming sufficient numbers of
patients existed, could a separate analysis of Hispanics pro-
vide an estimation of ethnic bias in the choice of surgical
intervention?
Distribution of disease is inferred from the site of oper-
ation. Because the procedural ICD-9 for percutaneous bal-
loon angioplasty does not specify the anatomic site of dilata-
tion, was percutaneous transluminal angioplasty considered
an infrainguinal or aortoiliac procedure? Did percutaneous
transluminal angioplasty show an association with race?
Finally, and most importantly, the explanation for
these racial differences really necessitates an examination
of the clinical data pertinent to the surgical decision mak-
ing. Do you foresee a mechanism by which your state data
collection could be modified or merged with these clinical
data for future analysis?
This paper and the topic it addresses are important,
and I appreciate the opportunity to open the discussion.
Dr Thomas S. Huber. Unfortunately, I am unable to
answer most of Dr Hansen’s questions. The patients were
identified in the study by their procedural code. All the
patients included in the study had undergone either an
amputation or a revascularization (angioplasty or surgical
bypass grafting). The dataset was then refined to look at
the patients that presumably underwent these procedures
for the complications of arterial occlusive disease. I do not
have the number of all those patients who underwent
amputation or revascualrization for any reason. We can
simply go back and pull that data. The overwhelming
majority of the revascularizations would have been per-
formed for complications of arterial occlusive disease. A
small subset of amputations would have been performed
for other indications.
The actual number of Hispanics is incomplete in our
dataset. We recently reported a study that looked at the
impact of the Asymtomatic Carotid Atherosclerosis Study in
the State of Florida with the same database. One of the
reviewers asked why we did not consider Hispanic patients
separately in the study, given the large population of
Hispanics. Our response to that and to the current questions
is that Hispanic is not a race but an ethnicity.
You asked whether percutaneous transluminal angio-
plasty was considered to be an infrainguinal or an aortoil-
iac bypass grafting procedure. It was considered a revascu-
larization. In the secondary analysis, we broke down the
type of surgical bypass grafting procedure. In this case, we
looked at infrainguinal versus aortoiliac bypass grafting.
The patients who had undergone percutaneous translumi-
nal angioplasty were excluded from that analysis.
How can we correlate this with our clinical observa-
tions? That remains the challenge. I think we pushed this
dataset as far as we can. It is an administrative database
designed to answer administrative questions. We have been
fortuitous to be able to answer a few clinical questions.
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